The major indexes are pulling back after yesterday's ceasefire-related surge
STAAR Surgical Company has seen a dramatic valuation reset, now trading at a $1bn market cap after failed acquisition talks and underwhelming US growth. Q1 2026 net sales are expected to exceed $90m,
STAAR Surgical (STAA) expects Q1 net sales to exceed $90M, more than doubling year-over-year, driven primarily by China and double-digit growth in the Americas. Disney plans 1,000 job cuts in marketin
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, t
Staar Surgical (STAA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Defender Capital LLC. purchased a new stake in shares of STAAR Surgical Company (NASDAQ: STAA) during the undefined quarter, according to the company in its most recent filing with the Securities and
STAAR Surgical Company (NASDAQ: STAA - Get Free Report) Director Broadwood Partners, L.P. purchased 316,017 shares of the business's stock in a transaction that occurred on Friday, March 13th. The sto
STAAR Surgical Company (NASDAQ: STAA - Get Free Report) Director Broadwood Partners, L.P. purchased 299,432 shares of the business's stock in a transaction on Thursday, March 12th. The shares were pur
STAAR Surgical Company (STAA) Q4 2025 Earnings Call Transcript
Staar Surgical (STAA) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.16 per share. This compares to a loss of $0.5 per share a year ago.

STAAR Surgical Issues Shareholder Letter

04:02pm, Tuesday, 03'rd Mar 2026
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, t
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, t
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, t
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, t
Merit Medical Systems (NASDAQ: MMSI - Get Free Report) and STAAR Surgical (NASDAQ: STAA - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesse
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE